December 20, 2022
Tag: Lisa Carey
December 6, 2022
UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
November 22, 2022
Targeted Oncology: Reviewing the Latest Advancements in Treatment of TNBC
October 4, 2022
Daily Tar Heel: NC organizations recognize Breast Cancer Awareness Month
September 27, 2022
Scientific retreat brings together cancer center community, offers insights across research fields
The UNC Lineberger annual scientific retreat featured faculty talks covering a range of basic, clinical/translational and population science research, as well as a poster session.
July 24, 2022
New York Times: After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices
April 8, 2022
AACR annual meeting to feature UNC Lineberger research
UNC Lineberger researchers and trainees will present nearly 20 research talks and presentations at the 2022 American Association for Cancer Research, April 8-13, in New Orleans.
January 25, 2022
Donor gives $25 million to establish UNC Lineberger Center for Triple Negative Breast Cancer
This is the largest donation in UNC Lineberger’s history, and it enables the cancer center to advance its groundbreaking research on diagnosing and treating a highly aggressive breast cancer that disproportionately affects Black, Latina and young women and historically has limited research funding.
January 18, 2022
Carey highlights progress in understanding and treating triple-negative breast cancer at San Antonio Breast Cancer Symposium
At the recent San Antonio Breast Cancer Symposium, Lisa A. Carey, MD, ScM, FASCO, presented a plenary talk on the latest developments in triple negative breast cancer.
July 26, 2021
National report on cancer offers hope, outlines challenges
Lisa A. Carey, MD, FASCO, says the report shows significant progress in some areas, but also outlines important shortcomings, especially in eliminating cancer-related racial disparities.